A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Shanghai Yunying Medical Technology
Revolution Medicines, Inc.
Blueprint Medicines Corporation
Shanghai Gebaide Biotechnology Co., Ltd.